Das Medizinportal     Aktuelles für medizinische Fachkreise
Menü

Das Medizinportal     Aktuelles für medizinische Fachkreise

Literatur:

Geschichtliche Entwicklung der kardiologischen Bildgebung 
Hermann Eichstädt, Rainer Röttgen, Bernadette Eichstädt, Thomas Störk, Holger Amthauer, Lukas Lehmkuhl und Matthias Gutberlet 

  1. Wicke, L.: Atlas der Röntgenanatomie. Urban & Schwarzenberg, München, 1985, S. X.
  2. Schadewaldt, H.: Die Einführung der Röntgenstrahlen in die Medizin. Dtsch Med Wschr 100, 2457 (1975)
  3. Riechmann, J.: Der Einfluß der Entdeckung der Röntgenstrahlen auf Diagnostik und Therapie. Med. Diss. Schr. Hannover, 2004
  4. Moritz, F.: Eine Methode, um beim Röntgenverfahren aus dem Schattenbilde eines Gegenstandes dessen wahre Größe zu ermitteln (Orthodiagraphie) und die exakte Bestimmung der Herzgröße nach diesem Verfahren. Münch. Med. Wschr. 29 (1900)
  5. Kauffmann, G., Moser, E., Sauer, R.: Radiologie. Urban & Schwarzenberg, München, 1996, S. 2.
  6. Dietlen, H.: Über die Größe und Lage des normalen Herzens und ihre Abhängigkeit von phy-siologischen Bedingungen. Dtsch. Arch. Klin. Med. 88, 55 (1907) 
  7. Groedel, F. M.: Grundriss und Atlas der Röntgendiagnostik in der inneren Medizin, J. F. Lehmanns, München, 1909
  8. Zdansky, E.: Röntgendiagnostik des Herzens und der großen Gefäße, Springer, Wien, 1939
  9. Reindell, H.: Kymographische und elektrokardiographische Befunde am Sportherzen. Dtsch. Arch. Klin. Med. 181, 485 (1938)
  10. Eichstädt, H.: Einfach-Klappenersatz bei Mitralvitien, präoperative Befunde in Relation zum Operationsrisiko. Med. Diss. Schr., Düsseldorf, 1973
  11. Felix, R.: Das Cor pulmonale. In: Röntgenologische Differentialdiagnostik, Band I: Thoraxor-gane, Teil 2: Herz, Hilus, Mediastinum. W. Teschendorf, H. Anacker, P. Thurn. Thieme, Stuttgart, 1977, S. 546.
  12. Feigenbaum, H.: Echocardiography, Lea & Febinger, Philadelphia, 1978
  13. Keidel, W. D.: New method of recording changes in volume of the human heart. Z Kreislaufforsch. 39, 9, 257 (1950)
  14. Edler, I., Hertz, C. H.: Use of ultrasonic reflectoscope for the continuous recording of the movements of heart walls. Kung Fysiograf Sallsk Lund Fordhandl. 24, 40, 1954.
  15. Effert, S., Erkens, H., Grosse-Brockhoff, F.: Ultrasonic echo method in cardiological diag-nosis. Germ. Med. Mth. 2, 325 (1957)
  16. Satomura S.: Ultrasonic Doppler method for the inspection of cardiac functions. J Acoust Soc Am. 29, 1181 (1957)
  17. Nagayama T, Hayakawa K, K no Y, Nakamura S: Ultrasonic Cardio-Kymogram. Medical Journal of Kagoshima University 14, 242 (1962)
  18. Fleischner, F. G.: Roentgenology of cor pulmonale and pulmonary hypertension. Trans Am Coll Cardiol. 7, 110 (1957)
  19. Gay, B. B.: Normal pulsations in the pulmonary vascular tree as seen with roentgenoscopic image amplification. Am J Roentgenol Radium Ther Nucl Med. 81, 801 (1959)
  20. Castellanos, A., Garcia, A.: La angiografia radio-opaca. Arch. Soc. Estud. Clin. Habana 31, 462 (1937)
  21. Cournand, A., Ranges, H. A.: Catheterization of the right auricle in man. Proc. Soc. Exper. Med. 46, 462 (1941)
  22. Löffler, L.: Die Kontrastmitteldarstellung der Herzhöhlen und der Lungengefäße am lebenden Menschen. 65. Tagung d. Dtsch. Ges. f. Chirurgie, Dresden, 1943
  23. Radner, S.: An attempt at the roentgenologic visualization of coronary blood vessels in men. Acta radiol. 26, 497 (1945) 
  24. Feigenbaum, H., Waldhausen, J. A., Hyde, L. P.: Ultrasound diagnosis of pericardial effusion. JAMA 191, 107 (1965)
  25. Winsberg, F., Gabor, G. E., Hergnberg, J. G.: Fluttering of the mitral valve in aortic insufficiency. Circulation41, 225 (1970)
  26. Popp, R. L., Harrison, D. C.: Ultrasound in the diagnosis and evaluationof therapy of idiopathic hypertrophic subaortic stenosis. Circulation 40, 905 (1969)
  27. Feigenbaum, H.: Ultrasound measurements of the left ventricle, a correlative study with an-giocardiography. Arch. Intern. Med. 129, 461 (1972)
  28. Baker, D.W., Nation, A.W.C., Strandness, D.E., Reid, J.M. Ultrasonic Duplex echo-Doppler scanner. IEEE Trans. Biomed. Eng 21, 109 (1974)
  29. Eichstädt, H., Bubenheimer, P., Ferber, B., Riesterer, H.: Welche Bedeutung hat die Echokar-diographie zur Beurteilung der linksventrikulären Hypertrophie. Verh. Dtsch. Ges. Kreislaufforschg. 43, 400 (1977)
  30. Blumgart, H. L., Weiss, S.: Studies on the velocity of blood flow. The pulmonary circulation time in normal resting subjects. J. clin. Invest. 4, 399 (1927)
  31. Burch, G. E., Threefoot, S. A., Ray, C.: The rate of disappearance of rubidium-86 from the plasma, the biologic decay rates of rubidium-86 and the applicability of rb-86 as a tracer of potassium in man with and without chronic congestive heart failure. J. Lab. Clin. Med. 45, 371 (1955)
  32. Sapirstein, L. A.: Fractionation of the cardiac output in rats with isotopic potassium. Circ. Res. 4, 689 (1956)
  33. Carr, E. A., Beierwaltes, W. H., Patno, M. E., Bartlett, J. D., Wegst, A. V.: The detection of experimental myocardial infarcts by photoscanning. Am. Heart J. 64, 650 (1962)
  34. Anger, H. O., van Dyke, D. C., Gottschalk, K.: The scintillation camera in diagnosis and research. Nucleonics 23, 57 (1965)
  35. Endo, M., Yamazaki, T., Konno, S., Hiratsuka, H.: The direct diagnosis of human myocardial ischemia using 131.J MAA via the selective coronary catheter. Am. Heart J. 80, 498 (1970)
  36. Quinn, J. L., Serratto, M., Kezdi, P.: Coronary artery bed photoscanning using radioiodine albumin macroaggregates (RA-MA). J. Nucl. Med. 7, 107 (1966)
  37. Ashburn, W. L., Braunwald, E., Simon, A. L.: Myocardial perfusion imaging with radioac-tive-labelled particlesinjected directly into the coronary circulation of patients with coronary artery disease. Circulation 44, 851 (1971)
  38. Jansen, C., Judkins, M. P., Grames, G. M., Gander, M., Adams, R.: Myocardial perfusion color scintigraphy with MAA. Radiology 109, 369 (1973)
  39. Felix, R., Thurn, P., Pensky, W.: Normales und pathologisches Perfusionsszintigramm des linksventrikulären Myokards und erste Ergebnisse des Thallium-201-Myokardszintigramms. In: Holtmeier, H. J., Siegenthaler, W.: Koronarinsuffizienz. Thieme, Stuttgart, 1975 
  40. Hamilton, G. W., Ritchie, J. L., Allen, D., Lapin, E., Murray, J. A.: Myocardial perfusion imaging with 99m-Tc or 113m-In macroaggregated albumin. Correlation of the perfusion image with clinical, angiographic, surgical, and histologic findings. Am. Heart J. 89, 708 (1975)
  41. Kawana, M., Krizek, H., Porter, J., Lathrop, A., Charleston, D., Harper, P. V.: Use of 199-Tl as a potassium analog in scanning. J. Nucl. Med. 11, 333 (1970)
  42. Lebowitz, E., Greene, M. W., Bradley-Moore, P., Atkins, H., Ansari, A., Richards, P., Belgrave, E.: Thallium-201 for medical use. J. Nuc. Medb. 14, 421 (1973)
  43. Lebowitz, E., Greene, M. W., Fairchild, R.: Thallium-201 for medical use. J. Nucl. Med. 16, 151 (1975)
  44. Strauss, H. W., Harrison, K., Langan, J. K., Lebowitz, E., Pitt, B.: Thallium-201 for myocardial imaging. Circulation, 51, 641 (1975) 
  45. Ritchie, J. L., Hamilton, G. W., Williams, D. L., English, M. T. Lebowitz, E.: Myocardial imaging with thallium-201, correlation with intracoronary macroaggregated albumin imaging. Circulation 52, 231 (1975) 
  46. Wackers F. J. T., v. d. Schoot, J. B., Sokole, E. B.: Noninvasive visualization of acute myo-cardial infarction in man with thallium-201. Brit. Heart J. 37, 741 (1975)
  47. Hör, G., Lichte, H., Pabst, H. W., Luther, M.: 201-Tl-Myokardszintigraphie bei Herzinfarkt. Compact News Nucl. Med. 5, 77 (1974) 
  48. Felix, R., Wagner, J., Pensky, W.: Die Myokardszintigraphie mit Thallium-201 als nicht-invasive Methode. Dtsch. Med. Wochenschr. 100, 2373 (1975)
  49. Bailey, I. K., Griffith, L. S. C., Strauss, H. W., Pitt, B.: Detection of coronary artery disease and myocardial ischemia by electrocardiography and myocardial perfusion scanning with thallium-201. Am. J. Cardiol. 37, 118 (1976)
  50. Parkey, R. W., Bonte, F. J., Stokely, E. M., Lewis, S. E., Graham, K. D., Buja, L. M., Willer-son, I. T.: Acute myocardial infarction imaged with 99m-Tc-stannous pyrophosphate and 201-Thallium, a clinical evaluation. J. Nucl. Med. 17, 771 (1976)
  51. Pohost, G. M., Beller, G. A., McKusick, K. A., Moore, R. H., Zir, L. M., Potsaid, M. S.: Thallium-201 redistribution following transient myocardial ischemia. J. Nucl. Med. 17, 535 (1976)
  52. Hör, G., Sebening, H., Sauer, E.: Clinical experience with 201-Tl-myocardial scintigraphy and ECG-gated blood pool scan. Herz 2, 215 (1977) 
  53. Felix, R., Pensky, W., Wagner, J.: Zur Zuverlässigkeit der Myokardszintigraphie mit Thallium-201. Vergleich mit der Laevokardiographie und der Perfusionsszintigraphie. Fortschr. Röntgenstr. 124, 210 (1976) 
  54. Bailey, I. K., Griffith, L. S. C., Rouleau, J. R., Strauss, H. W., Pitt, B.: Thallium-201 myo-cardial perfusion imaging at rest and during exercise. Circulation 55, 79 (1977) 
  55. Botvinick, E. H., Taradash, M. R., Shames, D. M. Parmey W. W.: Thallium-201 myocardial perfusion scintigraphy for the clinical clarification of normal, abnormal and equivocal electro-cardiographic stress tests. Am. J. Cardiol. 41, 43 (1978)
  56. Eichstädt, H., Schumacher, M., Feine, U., Kochsiek, K.: Rechnerunterstützte 201-Tl-Myokardszintigraphie in der Routinediagnostik der koronaren Herzerkrankung. Nuklearmedizin, 17, 233 (1978)
  57. Sauer,E., Sebening, H. Dressler, J.: Thallium-201-Serienmyokardszintigraphie bei koronarer Herzkrankheit. Vergleich mit der Elektrokardiographie und Koronarangiograthie. Z. Kardiol. 68, 454 (1979)
  58. DiCola V. C., Downing, S. E., Donabedian, R. K., Zaret, B. L.: Pathophysiological correlates of thallium-201 myocardial uptake in experimental infarction. Cardiovasc. Res. 11, 141 (1977) 
  59. Wackers, F. J. T., Sokole, E., Samson, G., Schoot, J. B., Lie, K. I., Durrer, D., Wellens, H. J.: Thallium-201 for visualization of acute myocardial infarction in the presence of left bundle branch block. Herz 2, 163 (1977)
  60. Berger, H. J., Gottschalk, A., Zaret, B. L.: Dual radionuclide study of acute myocardial infarc-tion: comparison of thallium-201 and technetium-99m stannous pyrophosphate imaging in man. Ann. Intern. Med. 88, 145 (1978)
  61. Anger, H. O.: A new instrument for mapping gamma-ray emitters. Biol. Med. Quart, Rep., UCRL 3653 (1957), S. 38
  62. Vogel, R. A., Kirch, D., LaFree, M.: A new method of multiplanar emission tomography using a seven pinhole collimator and an Anger scintillation camera. J. Nucl. Med. 19, 648 (1978) 
  63. Isherwood, I.: Neue Entwicklungen in der Computertomographie. In: J. Lissner (Hrsg.) Moderne Bildgebung, Ueberreuter Wissenschaft Verlag, Wien, Berlin, 1988, S. 16
  64. Eichstaedt, H.: Cardiovascular imaging in the nineties. In: Cardiovascular Nuclear Medicine and MRI. J. Reiber and E. v. d. Wall (Eds), Kluwer Academic Publishers, Dordrecht, 1992, p. 1 - 26.

Aktueller Entwicklungsstand der Echokardiographie
Thomas Okon, Dirk Schiller, Sebastian Spethmann

  1. Papolos A, Narula J, Bavishi C, Chaudhry FA, Sengupta PP. U.S. Hospital Use of Echocardiography: Insights From the Nationwide Inpatient Sample. Journal of the American College of Cardiology. 2016;67(5):502–11.
  2. Tarr A, Stobe S, Trache T, Kluge JG, Varga A, Pfeiffer D, et al. The impact of foreshortening on regional strain--a comparison of regional strain evaluation between speckle tracking and tissue velocity imaging. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2013;34(5):446–53.
  3. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM, et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2008; 21(11):1179–201; quiz 281.
  4. Porter TR, Abdelmoneim S, Belcik JT, McCulloch ML, Mulvagh SL, Olson JJ, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2014;27(8):797–810.
  5. Hoffmann R, von Bardeleben S, Kasprzak JD, Borges AC, ten Cate F, Firschke C, et al. Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods. Journal of the American College of Cardiology. 2006;47(1):121–8.
  6. Weinsaft JW, Kim RJ, Ross M, Krauser D, Manoushagian S, LaBounty TM, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovascular imaging. 2009;2(8):969–79.
  7. Hansen ML, Sorensen R, Clausen MT, Fog-Petersen ML, Raunso J, Gadsboll N, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Archives of internal medicine. 2010;170(16):1433–41.
  8. Chebrolu LH, Mehta AM, Nanda NC. Noncompaction cardiomyopathy: The role of advanced multimodality imaging techniques in diagnosis and assessment. Echocardiography (Mount Kisco, NY). 2017;34(2):279–89.
  9. Porter TR, Xie F. Myocardial perfusion imaging with contrast ultrasound. JACC Cardiovascular imaging. 2010;3(2):176–87.
  10. Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2012;25(1):3–46.
  11.  Mor-Avi V, Jenkins C, Kuhl HP, Nesser HJ, Marwick T, Franke A, et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JACC Cardiovascular imaging. 2008;1(4):413–23.
  12. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2015;28(1):1-39.e14.
  13. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2010; 23(7):685–713; quiz 86-8.
  14. Mertens LL, Friedberg MK. Imaging the right ventricle--current state of the art. Nature reviews Cardiology. 2010;7(10):551–63.
  15. Dandel M, Lehmkuhl H, Knosalla C, Suramelashvili N, Hetzer R. Strain and strain rate imaging by echocardiography - basic concepts and clinical applicability. Current cardiology reviews. 2009; 5(2):133–48.
  16. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Journal of the American Society of Echocardiography official publication of the American Society of Echocardiography. 2011; 24(3):277–313.
  17. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography--from technical considerations to clinical applications. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2007; 20(3):234–43.
  18. Costa SP, Beaver TA, Rollor JL, Vanichakarn P, Magnus PC, Palac RT. Quantification of the variability associated with repeat measurements of left ventricular two-dimensional global longitudinal strain in a real-world setting. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2014;27(1):50-4.
  19. Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU. Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors: The EACVI/ASE Inter-Vendor Comparison Study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2015;28(10):1171–81, e2.
  20. Mirea O, Pagourelias ED, Duchenne J, Bogaert J, Thomas JD, Badano LP, et al. Variability and Reproducibility of Segmental Longitudinal Strain Measurement: A Report From the EACVI-ASE Strain Standardization Task Force. JACC Cardiovascular imaging. 2017.
  21. Brecht A, Oertelt-Prigione S, Seeland U, Rucke M, Hattasch R, Wagelohner T, et al. Left Atrial Function in Preclinical Diastolic Dysfunction: Two-Dimensional Speckle-Tracking Echocardiography-Derived Results from the BEFRI Trial. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2016;29(8):750-8.
  22. Vitarelli A, Mangieri E, Terzano C, Gaudio C, Salsano F, Rosato E, et al. Three-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: diagnostic accuracy in detecting hemodynamic signs of right ventricular (RV) failure. Journal of the American Heart Association. 2015;4(3):e001584

Nuklearkardiologie: Methodik und klinische Wertigkeit
Carl Schlenkhoff, Xiao Wei, Florian C. Gaertner, Markus Essler

  1. Hellwig, D., et al., Nuklearmedizin in Deutschland. Aktualisierte Kennzahlen und Trends aus offiziellen Statistiken. Nuklearmedizin. Nuclear medicine, 2017. 56(2): p. 55–68.
  2. S. Kranz, M.G., High Volume Nuclear Cardiology using CZT Technique. Der Nuklearmediziner, 2017.
  3. Alkadhi H, L.S., Marincek B, et al., eds. Praxisbuch Herz-CT. 2009, Springer Springer Berlin Heidelberg: Heildelberg.
  4. Lindner, O., et al., [Myokard-Perfusions-SPECT. Myocardial perfusion SPECT - Update S1 guideline]. Nuklearmedizin, 2017. 56(4).
  5. Bundesärztekammer, K.B., Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Chronische Koronare Herzkrankheit: KHK. PatientenLeitlinie zur Nationalen VersorgungsLeitlinie.  16.07.2017]; 2. Auflage. Version 1. 2017:[
  6. Genders, T.S.S., et al., A clinical prediction rule for the diagnosis of coronary artery disease: Validation, updating, and extension. European heart journal, 2011. 32(11): p. 1316–1330.
  7. Montalescot, G., et al., 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European heart journal, 2013. 34(38): p. 2949–3003.
  8. Cerqueira, M.D., et al., Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol, 1994. 23(2): p. 384–9.
  9. Dakik, H.A., H. Vempathy, and M.S. Verani, Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging. J Nucl Cardiol, 1996. 3(5): p. 410–4.
  10. Ranhosky, A. and J. Kempthorne-Rawson, The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation, 1990. 81(4): p. 1205–9.
  11. Iskandrian, A.E., et al., Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol, 2007. 14(5): p. 645–58.
  12. Thomas, G.S., et al., Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol, 2008. 15(3): p. 319–28.
  13. Cerqueira, M.D., Pharmacologic stress versus maximal-exercise stress for perfusion imaging: which, when, and why? J Nucl Cardiol, 1996. 3(6 Pt 2): p. S10–4.
  14. Paul, A.K., et al., Exercise-induced stunning continues for at least one hour: evaluation with quantitative gated single-photon emission tomography. Eur J Nucl Med, 1999. 26(4): p.410–5.
  15. Sharir, T., et al., Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol, 2000. 86(11): p. 1171–5.
  16. Heber, D. and M. Hacker, Ischämielast versus Koronarmorphologie. Herz, 2016. 41(5): p. 376–383.
  17. Hachamovitch, R., et al., Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J, 2011. 32(8): p. 1012–24.
  18. Hachamovitch, R., et al., Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation, 2003. 107(23): p. 2900–7.
  19. Travin, M.I. and S.R. Bergmann, Assessment of myocardial viability. Seminars in nuclear medicine, 2005. 35(1): p. 2–16.
  20. Bax, J.J., et al., Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Current problems in cardiology, 2001. 26(2): p. 147–186.
  21. Lapa, C., et al., Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. Oncotarget, 2016. 7(47): p. 77807–77814.
  22. Jacobson, A.F., et al., Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol, 2010. 55(20): p. 2212–21.
  23. Nakajima, K. and T. Nakata, Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan. J Nucl Med, 2015. 56 Suppl 4: p. 11S–19S.

Koronare CT-Angiographie zur Abklärung der stabilen koronaren Herzkrankheit:
Auf dem Weg zur First-Line Diagnostik
Axel Schmermund

  1. https://www.destatis.de/DE/Zahlen-Fakten/GesellschaftStaat/Gesundheit/Todesursachen/Todesursachen.html (Zugang 30.7.2017).
  2. BaggishAL,Weiner RB, KanayamaG, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation 2017;135:1991−2002.
  3. BudoffMJ, Ellenberg SS, Lewis CE, et al. Testosterone treatment and coronary artery plaque volume in older menwith lowtestosterone. JAMA 2017;317:708−716.
  4. Lerman JB, JoshiAA, ChaturvediA, et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation 2017;136:263−276.
  5. HellMM, BittnerD, SchuhbäckA, et al. Prospectively ECG-triggered highpitch coronary angiographywith third-generation dual-source CT at 70 kVp tube voltage: feasibility, image quality, radiation dose, and effect of iterative reconstruction. J Cardiovasc Comput Tomogr 2014;8:418−425. 
  6. Schmermund A,Marwan M,Hausleiter J, et al.Declining radiation dose of coronary computed tomography angiography: German cardiac CT registry experience 2009−2014. Clin Res Cardiol 2017;106:905−912.
  7. Moreno PR,Narula J. Thinking outside the lumen: fractional flowreserve versus intravascular imaging formajor adverse cardiac event prediction. Jam Coll Cardiol 2014;63:1141−1144.
  8. Nielsen LH, BøtkerHE, SørensenHT, et al. Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: aDanishmulticentre cohort study. EurHeart J 2017;38:413−421.
  9. JørgensenME,Andersson C, Nørgaard BL, et al. Functional testing or coronary computed tomography angiography in patientswith stable coronary artery disease. JAmColl Cardiol 2017;69:1761−1770.
  10. Douglas PS,HoffmannU, PatelMR, et al.Outcomes of anatomical versus functional testing for coronary artery disease.NEngl JMed 2015;372:1291−1300.
  11. SCOT-HEART investigators. CT coronary angiography in patientswith suspected angina due to coronary heart disease (SCOT-HEART): anopen-label, parallel-group,multicentre trial. Lancet 2015;385:2383-2391; Erratumin: Lancet 2015;385:2354.
  12. HoffmannU, FerencikM,Udelson JE, et al. Prognostic value of noninvasive cardiovascular testing in patientswith stable chest pain: insights from the PROMISE trial (ProspectiveMulticenter Imaging Study for Evaluation of Chest Pain). Circulation 2017;135:2320−2332.
  13. WilliamsMC,HunterA, ShahAS, et al.Use of Coronary Computed TomographicAngiography toGuideManagement of PatientsWith Coronary Disease. JAmColl Cardiol 2016;67:1759−1768.
  14. Danad I, Szymonifka J, Twisk JWR, et al.Diagnostic performance of cardiac imagingmethods to diagnose ischaemia- causing coronary artery disease when directly comparedwith fractional flowreserve as a reference standard: ameta-analysis. EurHeart J 2017;38:991−998.
  15. Douglas PS,De Bruyne B, PontoneG, et al. 1-Year outcomes of FFRCT-guided care in patientswith suspected coronary disease - the PLATFORMstudy. Jam Coll Cardiol 2016;68:435−445.  
  16. MontalescotG, SechtemU,Achenbach S et al. 2013 ESC guidelines on themanagement of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. EurHeart J 2013;34:2949-3003; Erratumin: Eur Heart J 2014;35:2260−2261.

Kardio-MRT, Quantifizierung der LV-Funktion in Ruhe und unter Belastung
Lukas Stoiber; Tomas Lapinskas; Sebastian Kelle

  1. Sniderman, A.D., et al., Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events. JAMA Cardiol, 2016. 1(4): p. 492–4.
  2. 2. Piepoli, M.F., et al., 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2016. 37(29): p. 2315–81.
  3. Hamm, C.W., et al., ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2011. 32(23): p. 2999–3054.
  4. Sicari, R., et al., Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J, 2009. 30(3): p. 278–89.
  5. Amsterdam, E.A., et al., Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain. J Am Coll Cardiol, 2002. 40(2): p. 251–6.
  6. Kang, S.J., et al., Comparison of myocardial contrast echocardiography versus rest sestamibi myocardial perfusion imaging in the early diagnosis of acute coronary syndrome. J Cardiovasc Ultrasound, 2010. 18(2): p. 45–51.
  7. Sechtem, U., et al., Non-invasive imaging in acute chest pain syndromes. Eur Heart J Cardiovasc Imaging, 2012. 13(1): p. 69–78.
  8. Solomon, S.D., et al., Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J, 2016. 37(5): p. 455–62.
  9. Pieske, B., et al., Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J, 2017. 38(15): p. 1119–1127.
  10. Francis, S.A., et al., Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2013. 15: p. 52.
  11. A. Doltra, R.G., S. Kelle, Klinischer Nutzen einer Kardio-MRT-Untersuchung bei Patienten mit akutem Myokardinfarkt. Der Kardiologe, 2014. 8:78–84· DOI 10.1007/s12181-013-0546-8.
  12. Petrov, G., et al., Incremental cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in patients at intermediate risk for coronary artery disease. Clin Res Cardiol, 2015. 104(5): p. 401–9.
  13. Myerson, S.G., et al., Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension, 2002. 40(5): p. 673–8.
  14. Maceira, A.M., et al., Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2006. 8(3): p. 417–26.
  15. Grothues, F., et al., Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol, 2002. 90(1): p. 29–34.
  16. Cerqueira, M.D., et al., Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation, 2002. 105(4): p. 539–42.
  17. Morton, G., et al., Inter-study reproducibility of cardiovascular magnetic resonance myocardial feature tracking. J Cardiovasc Magn Reson, 2012. 14: p. 43.
  18. Onishi, T., et al., Feature tracking measurement of dyssynchrony from cardiovascular magnetic resonance cine acquisitions: comparison with echocardiographic speckle tracking. J Cardiovasc Magn Reson, 2013. 15: p. 95.
  19. Wu, V., et al., Evaluation of diastolic function by three-dimensional volume tracking of the mitral annulus with cardiovascular magnetic resonance: comparison with tissue Doppler imaging. J Cardiovasc Magn Reson, 2014. 16: p. 71.
  20. Eichstaedt, H.W., et al., Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol, 1986. 9(11): p. 527–35.
  21. Hundley, W.G., et al., ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol, 2010. 55(23): p. 2614–62.
  22. Bruder, O., et al., European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson, 2013. 15: p. 9.
  23. Doltra, A., et al., Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA. Eur Radiol, 2014. 24(9): p. 2192–200.
  24. Nagel, E., J. Schulz-Menger, O. Bruder, S. Kelle, H. Steen, T. J. Vogl, Zerebrale Gadoliniumablagerungen bei der Magnetresonanztomographie des Herzens. Der Kardiologe, 2016. DOI 10.1007/s12181-016-0092-2.
  25. Kelle, S., et al., A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients. J Am Coll Cardiol, 2013. 61(22): p. 2310–2.
  26. Hendel, R.C., et al., CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia. JACC Cardiovasc Imaging, 2016. 9(11): p. 1338–1348.